Nucleic Acid Therapeutics

Partner with Agilent's Nucleic Acid Solutions division and benefit from industry-leading experience to efficiently advance your lead oligo candidates from clinic to market. We share your goal of patient health and safety.

Collaboration is important to a successful strategy. Many biotech and pharma companies manufacturing oligo APIs increase their chances of success by partnering with an experienced development partner, like Agilent. We can help you make decisions, solve technical problems, and save money at critical points in the manufacture of nucleic acid therapeutics under good manufacturing practice.